Tradestie Institutional Equity Comparison Engine
BGM vs ONCY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ONCY Overall Edge
ONCY Captures Institutional Edge (2โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Oncolytics Biotech, Inc. Common Shares (ONCY) driven by superior Valuation, Growth & Margin while BGM counters with relative strength in Momentum & Technical. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus ONCY at 45.5x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ONCY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ONCY
BGM N/M vs ONCY 45.5x Fwd P/E
Growth & Margin Winner
ONCY
Op Margin -23.4% vs 0.0% ยท YoY +69.8% vs +0.0%
Momentum & Technical Winner
BGM
1Y -17.5% vs -66.3% ยท 52W Pos 74% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
ONCY
NASDAQ
Oncolytics Biotech, Inc. Common Shares
Pharmaceutical Preparations
$0.35
-10.37% 1D
Market Cap
$53.2M
1M Return
-30.01%
1Y Return
-66.34%
Forward P/E
45.5x
Unified AI Score
44.5 / 100
HOLD
Tech 50.0
Fund 59.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGM -17.53%
ONCY -66.34%
Spread: +56.67 pp (BGM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGM TTM Op. Margin: -23.4%
ONCY TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs ONCY. Trailing 12-month operating profitability (BGM -23.4% vs ONCY 0.0%) and valuation multiples (BGM N/M vs ONCY 45.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGM | ONCY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $108.6M | $53.2M | Larger Scale | BGM |
| Trailing P/E Ratio Valuation | N/M | 45.5x | Lower Multiple | ONCY |
| Forward P/E Ratio Valuation | N/M | 45.5x | Lower Multiple | ONCY |
| Revenue Growth (YoY) Growth | +69.8% | +0.0% | Higher Growth | BGM |
| Operating Margin (TTM) Profitability | -23.4% | 0.0% | Higher Margin | ONCY |
| Net Profit Margin Profitability | -44.2% | 0.0% | Higher Margin | ONCY |
| Return on Equity (ROE) Capital Efficiency | -7.4% | -769.1% | Higher ROE | BGM |
| 52-Week Range Position Momentum | 74% ($0โ$11) | 2% ($0โ$1) | Stronger Trend | BGM |
| Beta / 30D Volatility Risk Regime | 3.69ฮฒ ยท 80% Vol | 1.34ฮฒ ยท 117% Vol | Lower Realized Risk | BGM |
| Unified Institutional Score Composite Signal | 59.6 / 100 (HOLD) | 44.5 / 100 (HOLD) | Higher Composite | BGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGM vs ONCY Buy Guide
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ONCY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGM nor ONCY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.